Clinical Trial Details
EORTC-08061
Back to Clinical Trials Database
Phase II study of sunitinib (SU11248) in patients with small cell lung cancer who are either chemo-naïve (extensive disease) or have a "sensitive" relapse.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 19-Feb-2009 Date Step1 close: 09-Jul-2010 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 48 - All Groups: 48 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00953459 |
| NCT number | NCT00953459 |
| EudraCT | 2006-002485-19 |
